Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6055338 | Oral Oncology | 2011 | 6 Pages |
Abstract
Concurrent chemoradiotherapy appeared to improve the 5-year RFS rate for patients with T2N1M0 NPC. Large prospective, randomized clinical studies are needed to confirm its therapeutic gain.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Tingting Xu, Chaosu Hu, Xiaoshen Wang, Chunying Shen,